NSAID transdermal patch efficacy being tested for minor sports injuries at UCSF.
This article was originally published in The Tan Sheet
Executive Summary
NSAID TRANSDERMAL PATCH EFFICACY FOR MINOR SPORTS INJURIES being evaluated in a double-blind, placebo-controlled clinical trial at the University of California at San Francisco Pain Clinical Research Center. The study is testing continuous transdermal administration of the nonsteroidal anti-inflammatory drug diclofenac sodium at the site of injury for a period of two weeks. Ciba sells the NSAID as prescription Voltaren in the U.S. but diclofenac has been switched to OTC status in the U.K. and France and is a likely candidate for a U.S. switch as well.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning